Cargando…

A novel designer natriuretic peptide CD-NP suppresses TGF-beta 1 induced collagen Type I production in human cardiac fibroblasts

Detalles Bibliográficos
Autores principales:	Ichiki, Tomoko, Huntley, Brenda K, Sangaralingham, S Jeson, Chen, Horng H, Burnett, John C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313338/ http://dx.doi.org/10.1186/1471-2210-9-S1-P27

Ejemplares similares

CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the Heart
por: Martin, Fernando L., et al.
Publicado: (2012)

M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics
por: McKie, Paul M, et al.
Publicado: (2013)

M‐Atrial Natriuretic Peptide and Nitroglycerin in a Canine Model of Experimental Acute Hypertensive Heart Failure: Differential Actions of 2 cGMP Activating Therapeutics
por: McKie, Paul M., et al.
Publicado: (2014)

Natriuretic peptide pathways in heart failure: further therapeutic possibilities
por: Sangaralingham, S Jeson, et al.
Publicado: (2022)

C-type natriuretic peptide: the heart’s guardian angel
por: Sangaralingham, S Jeson, et al.
Publicado: (2020)

Early activation of deleterious molecular pathways in the kidney in experimental heart failure with atrial remodeling
por: Ichiki, Tomoko, et al.
Publicado: (2017)

A biodegradable in-situ polymer precipitation delivery system for sustained delivery of a novel chimeric natriuretic peptide CD-NP in an experimental model of myocardial infarction
por: Lim, Soo Ghim, et al.
Publicado: (2013)

Cenderitide, a novel dual GC-A and GC-B receptor activator, is a potent chronic cardiorenal fibroinhibiting peptide which suppresses aldosterone and reduces proteinuria in models of ardiorenal fibrosis
por: Martin, Fernando L, et al.
Publicado: (2011)

Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolism
por: Glöde, Anja, et al.
Publicado: (2017)

Mutation of three amino acids in the disulfide-ring of a CNP based chimeric natriuretic peptide alters its vascular properties
por: Chen, Horng H, et al.
Publicado: (2009)

Treatment with CBA-NP a novel chimeric natriuretic peptide attenuates cardiorenal fibrosis and improves diastolic dysfunction in diabetic rat model
por: Ameenuddin, Syed, et al.
Publicado: (2011)

EVIDENCE FOR ANGIOTENSIN II AS A NATURALLY EXISTING SUPPRESSOR FOR THE NATRIURETIC PEPTIDE SYSTEM
por: Ma, Xiao, et al.
Publicado: (2023)

Chronic natriuretic peptide protein therapeutics
por: Chen, Horng H, et al.
Publicado: (2013)

C-Type natriuretic peptide: a potential urinary biomarker for renal remodeling and fibrosis during aging
por: Sangaralingham, Jeson S, et al.
Publicado: (2011)

Krait natriuretic peptide (KNP): a non-classical NP
por: Sridharan, Sindhuja, et al.
Publicado: (2013)

AC-NP: A Novel Chimeric Peptide with Natriuretic and Vasorelaxing Actions
por: Chen, Bao-Ying, et al.
Publicado: (2011)

Natriuretic Peptide-Based Novel Therapeutics: Long Journeys of Drug Developments Optimized for Disease States
por: Ichiki, Tomoko, et al.
Publicado: (2022)

C-type natriuretic peptide stimulates osteoblastic proliferation and collagen-X expression but suppresses fibroblast growth factor-23 expression in vitro
por: Chen, Wei Xia, et al.
Publicado: (2020)

The novel dual GC-A and GC-B designer natriuretic peptide, cenderitide (CD-NP), enhances the renal actions of furosemide in a model of severe heart failure
por: Costello-Boerrigter, Lisa C, et al.
Publicado: (2011)

Progressive decline in circulating CNP with aging is associated with progressive cardiac fibrosis and myocardial impairment
por: Sangaralingham, Jeson, et al.
Publicado: (2009)

In-Vivo Evaluation of an In Situ Polymer Precipitation Delivery System for a Novel Natriuretic Peptide
por: Lim, Soo Ghim, et al.
Publicado: (2013)

Innovative Therapeutics: Designer Natriuretic Peptides
por: Meems, Laura M.G., et al.
Publicado: (2016)

The Importance of Natriuretic Peptides in Cardiometabolic Diseases
por: Vinnakota, Shravya, et al.
Publicado: (2020)

A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure
por: Kawakami, Rika, et al.
Publicado: (2018)

Inhibition of basal and TGF beta-induced fibroblast collagen synthesis by antineoplastic agents. Implications for wound healing.
por: Hendricks, T., et al.
Publicado: (1993)

Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011)

Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009)

Resetting the neurohormonal balance in heart failure (HF): the relevance of the natriuretic peptide (NP) system to the clinical management of patients with HF
por: Rubattu, Speranza, et al.
Publicado: (2017)

Cell Surface Protein Disulfide Isomerase Regulates Natriuretic Peptide Generation of Cyclic Guanosine Monophosphate
por: Pan, Shuchong, et al.
Publicado: (2014)

Heads and Tails of Natriuretic Peptides: Neuroprotective Role of Brain Natriuretic Peptide
por: Fernández‐Susavila, Héctor, et al.
Publicado: (2017)

Arterial Remodeling in B-Type Natriuretic Peptide Knock-Out Females
por: Holditch, Sara J., et al.
Publicado: (2016)

C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice
por: Kimura, Toru, et al.
Publicado: (2016)

Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A
por: Vink, Simone, et al.
Publicado: (2023)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

The degree of natriuretic peptide system activation in stable and high risk CHF characterized by increased cystatin C is not reflected in cGMP activation
por: Schirger, John A, et al.
Publicado: (2009)

Plasmid-encoded NP73-102 modulates atrial natriuretic peptide receptor signaling and plays a critical role in inducing tolerogenic dendritic cells
por: Zhang, Weidong, et al.
Publicado: (2011)

Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure
por: Costello-Boerrigter, Lisa C, et al.
Publicado: (2011)

Erratum to: C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice
por: Kimura, Toru, et al.
Publicado: (2016)

A novel natriuretic peptide
por: Höfeld, Hanna, et al.
Publicado: (2011)

Natriuretic peptides and fat metabolism
por: Collins, Sheila
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lmlpif9cnl60m298brv9gn87a4